S.Africa’s Aspen signs deal paving way for J&J COVID vaccine licence
(Refiles to remove extraneous word in paragraph 2) By Promit Mukherjee JOHANNESBURG (Reuters) -South Africa’s Aspen Pharmacare took a step towards a licensing deal to package and sell Johnson & Johnson’s COVID-19 vaccine in Africa, announcing on Tuesday it had signed non-binding terms with subsidiaries of the U.S. drugmaker. While Aspen did not give a …
S.Africa’s Aspen signs deal paving way for J&J COVID vaccine licence Read More »